HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Reading Ashton Selected Research

Autoantigens

3/2019Recombinant AAV-CEA Tumor Vaccine in Combination with an Immune Adjuvant Breaks Tolerance and Provides Protective Immunity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Reading Ashton Research Topics

Disease

3Neoplasms (Cancer)
11/2022 - 03/2019
2Breast Neoplasms (Breast Cancer)
11/2022 - 12/2020
1Hematologic Neoplasms (Hematological Malignancy)
11/2022
1Colonic Neoplasms (Colon Cancer)
03/2019

Drug/Important Bio-Agent (IBA)

2Proteins (Proteins, Gene)FDA Link
12/2020 - 03/2019
1Single-Chain AntibodiesIBA
11/2022
1Immune Checkpoint InhibitorsIBA
11/2022
1Death Domain ReceptorsIBA
12/2020
1TNF-Related Apoptosis-Inducing LigandIBA
12/2020
1LigandsIBA
12/2020
1OsteoprotegerinIBA
12/2020
1AutoantigensIBA
03/2019
1VaccinesIBA
03/2019

Therapy/Procedure

2Therapeutics
11/2022 - 12/2020
1Immunotherapy
03/2019